Mesoblast Limited Form 6-K furnishes AGM and press release exhibits

Rhea-AI Filing Summary

Mesoblast Limited submitted a Form 6-K to provide U.S. investors with materials it filed with the Australian Securities Exchange. The report states that on November 25, 2025, the company lodged the Chair’s Annual General Meeting address and the CEO’s presentation to the Annual General Meeting, which are included as Exhibits 99.1 and 99.2. It also includes a press release dated the same day as Exhibit 99.3. These documents are incorporated by reference, making the Australian-market communications available to investors following Mesoblast’s U.S. listing.

Form 6-K: How Foreign Companies Report to the SEC →

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

For the month of November 2025

Commission File Number 001-37626

Mesoblast Limited

(Exact name of Registrant as specified in its charter)

Not Applicable

(Translation of Registrant’s name into English)

Australia
(Jurisdiction of incorporation or organization)

Silviu Itescu

Chief Executive Officer and Executive Director

Level 38

55 Collins Street

Melbourne 3000

Australia

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F:

Form 20-F ☑ Form 40-F ☐

INFORMATION CONTAINED ON THIS REPORT ON FORM 6-K

On November 25, 2025, Mesoblast Limited filed with the Australian Securities Exchange the Chair’s Annual General Meeting address and CEO presentation to Annual General Meeting, which are attached hereto as Exhibit 99.1 and Exhibit 99.2, and are incorporated herein by reference.

On November 25, 2025, Mesoblast Limited filed with the Australian Securities Exchange a new release announcement, which is attached hereto as Exhibit 99.3, and is incorporated herein by reference.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly organized.

Mesoblast Limited

/s/ Paul Hughes

Paul Hughes

Company Secretary

Dated: November 25, 2025

INDEX TO EXHIBITS

Item
99.1						Chair’s Annual General Meeting address, dated November 25, 2025.
99.2						CEO Presentation to Annual General Meeting, dated November 25, 2025.
99.3						Press release of Mesoblast Ltd, dated November 25, 2025.

FAQ

What did Mesoblast Limited (MESO) report in this Form 6-K?

Mesoblast Limited reported that it filed its Chair’s Annual General Meeting address, the CEO’s Annual General Meeting presentation, and a press release as exhibits, all dated November 25, 2025.

Which documents are attached to Mesoblast Limited’s Form 6-K as exhibits?

The Form 6-K includes three exhibits: 99.1 Chair’s Annual General Meeting address, 99.2 CEO presentation to the Annual General Meeting, and 99.3 a press release of Mesoblast Ltd, each dated November 25, 2025.

Why did Mesoblast Limited file these AGM materials with the SEC?

As a foreign private issuer, Mesoblast Limited uses Form 6-K to furnish important information it filed with the Australian Securities Exchange, so U.S. investors can access the Chair’s AGM address, CEO presentation, and related press release.

Who signed Mesoblast Limited’s Form 6-K dated November 25, 2025?

The Form 6-K was signed on behalf of Mesoblast Limited by Paul Hughes, the Company Secretary.

Does this Mesoblast (MESO) Form 6-K include financial results or transaction details?

This Form 6-K primarily identifies and furnishes the Chair’s AGM address, CEO AGM presentation, and a press release as exhibits; any detailed financial or operational information would appear within those attached documents.